Sanguine
Gerald Lee is the Chief Product Officer at Sanguine. Gerald was previously a research at Stanford University from January 2008 to December 2011. Gerald led a grant-funded project researching the autologous T-cell immune response in patients with Chronic Myeloid Leukemia (CML).
Gerald Lee earned their BS in Molecular, Cellular, and Developmental Biology from the University of California, Los Angeles.
Some of their coworkers include Katherine Yee - Associate Director, Study Design And Feasibility, Chelsea C. Caro - Associate Director, Sales Development, and Jennifer Banks - Associate Director, Clinical Research Project Management. Gerald Lee reports to Brian Neman, CEO & Co-Founder.
This person is not in any offices
Sanguine
4 followers
Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. They partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample collection criteria.